Sysmex Corporation SSMXY OTC · Healthcare · Japan
$13.33 +3.15% +$0.41
Summary
68 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: ¥121.4B against ¥119.5B.
- Out of every 100 JPY of revenue, 13 JPY is left as free cash.
What to watch
- You pay 35.9 JPY for 1 JPY of yearly profit, a lot for its sector.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBy our assumptions the price matches the value of the business: the two differ by less than 10 %.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 35.9 JPY for 1 JPY of yearly profit. Over the last five years it was 34.1 JPY on average.
Valuation in detailIs it growing?
SlowlyRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 8.9% a year. For the next fiscal year analysts expect revenue to grow by 3.0%.
Growth in detailDoes it make money?
Very wellWhere 100 JPY of revenue goes
- Cost of sales 49 JPY
- Research and development 5.8 JPY
- Sales and administration 32 JPY
- Taxes and other 6.8 JPY
- Net profit 6.4 JPY
Net profit, industry median (Medical - Specialties) 8.1 JPY
Out of every 100 JPY of revenue, 6.4 JPY is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.6 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 1.72%
- Paid out of profit
- 62%
- Raised in a row
- 1 year
You receive $0.22 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.